| Literature DB >> 35732829 |
Rita Alaggio1, Catalina Amador2, Ioannis Anagnostopoulos3, Ayoma D Attygalle4, Iguaracyra Barreto de Oliveira Araujo5, Emilio Berti6, Govind Bhagat7, Anita Maria Borges8, Daniel Boyer9, Mariarita Calaminici10, Amy Chadburn11, John K C Chan12, Wah Cheuk12, Wee-Joo Chng13, John K Choi14, Shih-Sung Chuang15, Sarah E Coupland16, Magdalena Czader17, Sandeep S Dave18, Daphne de Jong19, Ming-Qing Du20, Kojo S Elenitoba-Johnson21, Judith Ferry22, Julia Geyer11, Dita Gratzinger23, Joan Guitart24, Sumeet Gujral25, Marian Harris26, Christine J Harrison27, Sylvia Hartmann28, Andreas Hochhaus29, Patty M Jansen30, Kennosuke Karube31, Werner Kempf32, Joseph Khoury33, Hiroshi Kimura34, Wolfram Klapper35, Alexandra E Kovach36, Shaji Kumar37, Alexander J Lazar38, Stefano Lazzi39, Lorenzo Leoncini39, Nelson Leung40, Vasiliki Leventaki41, Xiao-Qiu Li42, Megan S Lim21, Wei-Ping Liu43, Abner Louissaint44, Andrea Marcogliese45, L Jeffrey Medeiros33, Michael Michal46, Roberto N Miranda33, Christina Mitteldorf47, Santiago Montes-Moreno48, William Morice49, Valentina Nardi44, Kikkeri N Naresh50, Yasodha Natkunam23, Siok-Bian Ng51, Ilske Oschlies35, German Ott52, Marie Parrens53, Melissa Pulitzer54, S Vincent Rajkumar55, Andrew C Rawstron56, Karen Rech49, Andreas Rosenwald3, Jonathan Said57, Clémentine Sarkozy58, Shahin Sayed59, Caner Saygin60, Anna Schuh61, William Sewell62, Reiner Siebert63, Aliyah R Sohani44, Reuben Tooze64, Alexandra Traverse-Glehen65, Francisco Vega33, Beatrice Vergier66, Ashutosh D Wechalekar67, Brent Wood36, Luc Xerri68, Wenbin Xiao54.
Abstract
We herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.Entities:
Mesh：
Year: 2022 PMID： 35732829 PMCID： PMC9214472 DOI： 10.1038/s41375-022-01620-2
Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 12.883